NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study

par Leal, Alexis D., Qin, Rui, Atherton, Pamela J., Haluska, Paul, Behrens, Robert J., Tiber, Charles, Watanaboonyakhet, Patanit, Weiss, Matthias, Adams, Paul T., Dockter, Travis, Loprinzi, Charles L.
Publié 2014

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

par Holtan, Shernan G., Steen, Preston D., Foster, Nathan R., Erlichman, Charles, Medeiros, Fabiola, Ames, Matthew M., Safgren, Stephanie L., Graham, David L., Behrens, Robert J., Goetz, Matthew P.
Publié 2012

Assessment of Long-Term Rectal Function in Patients Who Received Pelvic Radiotherapy: A Pooled North Central Cancer Treatment Group Trial Analysis, N09C1

par Brown, Lindsay C., Atherton, Pamela J., Neben-Wittich, Michelle A., Wender, Donald B., Behrens, Robert J., Kozelsky, Timothy F., Loprinzi, Charles L., Haddock, Michael G., Martenson, James A.
Publié 2013

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222

par Mc Kean, Heidi, Stella, Philip J., Hillman, Shauna L., Rowland, Kendrith M., Cannon, Michael W., Behrens, Robert J., Gross, Gerald G., Sborov, Mark D., Friedman, Eliot L., Jatoi, Aminah
Publié dans Cancer Invest (2011)

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

par Sideras, Kostandinos, Dueck, Amylou C., Hobday, Timothy J., Rowland, Kendrith M., Allred, Jacob B., Northfelt, Donald W., Lingle, Wilma L., Behrens, Robert J., Fitch, Tom R., Nikcevich, Daniel A., Perez, Edith A.
Publié 2012

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

par Srivastava, Geetika, Renfro, Lindsay A., Behrens, Robert J., Lopatin, Margarita, Chao, Calvin, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, J. Philip, Kim, George, Mazurczak, Miroslaw, Lee, Mark, Alberts, Steven R.
Publié 2014

Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)

par Boora, Ganesh K., Kulkarni, Amit A., Kanwar, Rahul, Beyerlein, Peter, Qin, Rui, Banck, Michaela S., Ruddy, Kathryn J., Pleticha, Josef, Lynch, Cynthia A., Behrens, Robert J., Züchner, Stephan, Loprinzi, Charles L., Beutler, Andreas S.
Publié dans J Neurol Sci (2015)

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

par Alberts, Steven R., Yu, Tiffany M., Behrens, Robert J., Renfro, Lindsay A., Srivastava, Geetika, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, John P., Kim, George P., Mazurczak, Miroslaw A., Hornberger, John
Publié dans Pharmacoeconomics (2014)

Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group study N0074 ()

par Uhm, Joon H., Ballman, Karla V., Wu, Wenting, Giannini, Caterina, Krauss, JC, Buckner, Jan C., James, C.D, Scheithauer, Bernd W., Behrens, Robert J., Flynn, Patrick J., Schaefer, Paul L., Dakhill, Shaker R., Jaeckle, Kurt A.
Publié dans Int J Radiat Oncol Biol Phys (2010)

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

par Siziopikou, Kalliopi P., Anderson, Stewart J., Cobleigh, Melody A., Julian, Thomas B., Arthur, Douglas W., Zheng, Ping, Mamounas, Eleftherios P., Pajon, Eduardo R., Behrens, Robert J., Eakle, Janice F., Leasure, Nick C., Atkins, James N., Polikoff, Jonathan A., Seay, Thomas E., McCaskill-Stevens, Worta J., Rabinovitch, Rachel, Costantino, Joseph P., Wolmark, Norman
Publié dans Breast Cancer Res Treat (2013)

Induction vs no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in esophageal adenocarcinoma: a multicenter randomized phase II trial (NCCTG N0849 [Alliance...

par Yoon, Harry H., Ou, Fang-Shu, Soori, Gamini S., Shi, Qian, Wigle, Dennis A., Sticca, Robert P., Miller, Robert Clell, Leenstra, James L., Peller, Patrick J., Ginos, Brenda, Heying, Erica, Wu, Tsung-Teh, Drevyanko, Timothy F., Ko, Stephen, Mattar, Bassam Ibrahim, Nikcevich, Daniel A., Behrens, Robert J., Khalil, Maged F., Kim, George P., Alberts, Steven R.
Publié dans Eur J Cancer (2021)